Topical antibiotics for acute rhinosinusitis in children
https://doi.org/10.21518/2079-701X-2020-6-50-56
Abstract
In this article, the authors provide an overview of existing data on the use of topical antibacterial drugs in acute rhinosinusitis in children. General information on the etiology of acute rhinosinusitis is given. Indications for systemic and topical antibiotic therapy in acute rhinosinusitis are noted, indicated in Russian and international consensus documents. The advantages of using the combined preparation of thiamphenicol and N-acetylcysteine in acute rhinosinusitis in children and adults are considered separately. It is concluded that the topical antibacterial therapy of acute rhinosinusitis, despite all its advantages, is not an equivalent substitute for systemic antibacterial therapy in the treatment of severe and, especially, complicated forms of acute rhinosinusitis. The practitioner should be guided by the indications for systemic and topical antibacterial therapy adopted in Russian consensus documents. If there are indications for systemic antibiotic therapy, local remedies are only ancillary treatment, the action of which is aimed at enhancing the effect of systemic antibiotics. In the case of monotherapy with local drugs containing antibacterial components, it is mandatory to re-evaluate the patient’s condition and the dynamics of the symptoms of the disease for 2–3 days of treatment, and in the absence of positive changes, reconsider the need for systemic antibacterial therapy. More promising is the use of combined drugs that, in addition to affecting the causative agent of the disease, achieve anti-inflammatory, decongestion or mucolytic effects. It is convenient and rational to use nasal sprays, however, in order to improve the delivery of the active substance to the site of inflammation in acute rhinosinusitis, the use of nebulizer is justified.
About the Authors
E. P. KarpovaRussian Federation
Elena P. Karpova, Dr. of Sci. (Med.), Professor, Head of Chair for Paediatric Otorhinolaryngology
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
D. A. Tulupov
Russian Federation
Denis A. Tulupov, Cand. of Sci. (Med.), Associate Professor, Chair for Pediatric Otorhinolaryngology
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
I. V. Zyabkin
Russian Federation
Ilya V. Zyabkin, Cand. of Sci. (Med.), Assistant, Associate Professor, Chair for Paediatric Otorhinolaryngology
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
References
1. Kozlov R.S., Zyrianov S.K., Sinopalnikov A.I., Riazantsev S.V., Styrt E.A. Expert Council Resolution Empirical antibacterial treatment of respiratory tract infections taking into account risk factors for resistant flora. Spravochnik poliklinicheskogo vracha = Polyclinic Practitioner’s Reference. 2018;(1):28–32. (In Russ.) Available at: https://elibrary.ru/item.asp?id=32706819.
2. Harris A.M., Hicks L.A., Qaseem A. High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and prevention. Ann Intern Med. 2016;164(6):425–434. doi: 10.7326/M15-1840.
3. Fokkens W., Lund V., Mullol J., Bachert C., Alobid I., Baroody F. et al. European position paper on rhinosinusitis and nasal polyps 2012 (EP3OS). Rhinology. 2012;50(23):1–299. doi: 10.4193/Rhino50E2.
4. Herlø Herløv-Nielsen H., Højby N. Sinusitis is common in small children. Ugeskr Laeger. 2010;172(48):3320–3325. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21118660.
5. Cronin M.J., Khan S., Saeed S. The role of antibiotics in the treatment of acute rhinosinusitis in children: a systematic review. Arch Dis Child. 2013;98(4):299–303. doi: 10.1136/archdischild-2012-302983.
6. Babar-Craig H., Gupta Y., Lund V.J. British Rhinological Society audit of the role of antibiotics in complications of acute rhinosinusitis: a national prospective audit. Rhinology. 2010;48(3):344–347. doi: 10.4193/rhin09.130.
7. Hansen F.S., Hoffmans R., Georgalas C., Fokkens W.J. Complications of acute rhinosinusitis in The Netherlands. Fam Pract. 2012;29(2):147–153. doi: 10.1093/fampra/cmr062.
8. Riazantsev S.V., Karneeva O.V., Garashenko T.I., Gurov A.V., Svistushkin V.M., Sapova K.I. et al. Acute sinusitis. Practice Guideline. 2016. (In Russ.) Available at: http://www.nmaoru.org/files/KR313%20Ostryj%20sinusit.pdf.
9. Benninger M.S., Holy C.E., Trask D.K. Acute Rhinosinusitis: Prescription Patterns in a Real-World Setting. Otolaryngol Head Neck Surg. 2016;154(5):957–962. doi: 10.1177/0194599816630310.
10. Rachina S.A., Kozlov R.S., Tatochenko V.K., Zharova L.P., Dudnikova E.V., Sakulina I.B. et al. Paediatricians approach to prescribing of systemic antimicrobials in outpatient children with upper respiratory tract and ENT infections: data from multicenter survey. Klinicheskaya farmakologiya i terapiya = Clinical Pharmacology and Therapy. 2016;(2):20–27. (In Russ.) Available at: https://clinpharm-journal.ru/articles/2016-2/praktika-lecheniya-ostryh-respiratornyh-infektsij-u-detej-v-ambulatorno-poliklinicheskih-uchrezhdeniyah-rf-rezultaty-mnogotsentrovogo-farmakoepidemiologicheskogo-issledovaniya/
11. .Shehab N., Patel P.R., Srinivasan A., Budnitz D.S. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–743. doi: 10.1086/591126.
12. Geppe N.A., Malyavina U.S., Dronov I.A., Titova E.L. A new technology in the treatment of rhinosinusitis in children. Doktor.Ru = Doctor.Ru. 2010;1(52):7–10. (In Russ.) Available at: https://elibrary.ru/item.asp?id=14981930.
13. Ivanchik N.V., Chagaryan А.N., Sukhorukova М.V., Kozlov R.S., Dekhnich А.V., Krechikova О.I. et. al. Antimicrobial resistance of clinical Streptococcus pneumoniae isolates in Russia: the results of multicenter epidemiological study PEHASus 2014–2017. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy. 2019;21(3):230–238. (In Russ.) doi: 10.36488/cmac.2019.3.230-237.
14. Sivaya O.V., Kozlov R.S., Krechikova O.I., Ivanchik N.V., Katosova L.K., Gudkova L.V. and PeGASus Study Group. Antimicrobial Resistance of Haemophilus influenzae in Russia: Results of Multicenter Study PeGASus. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy. 2014;16(1):57–69. (In Russ.) Available at: https://cmac-journal.ru/publication/2014/1/cmac-2014-t16n1-p057/cmac-2014-t16-n1-p057.pdf.
15. Pérez-Giraldo C., Rodríguez-Benito A., Morán F.J., Hurtado C., Blanco M.T., Gómez-García A.C. Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother. 1997;39(5):643–646. doi: 10.1093/jac/39.5.643.
16. Aslam S., Darouiche R.O. Role of antibiofilm-antimicrobial agents in controlling device-related infections. Int J Artif Organs. 2011;34(9):752–758. doi: 10.5301/ijao.5000024.
17. Orlandi R.R., Kingdom T.T., Hwang P.H., Smith T.L., Alt J.A., Baroody F.M. et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(1):22–209. doi: 10.1002/alr.21695.
18. Serra A., Schito G.C., Nicoletti G., Fadda G. A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route). Int J Immunopathol Pharmacol. 2007;20(3):607–617. doi: 10.1177/039463200702000319.
19. Wei J.L., Sykes K.J., Johnson P., He J., Mayo M.S. Safety and efficacy of oncedaily nasal irrigation for the treatment of pediatric chronic rhinosinusitis. Laryngoscope. 2011;121(9):1989–2000. doi: 10.1002/lary.21923.
20. Barazi R., Bawab I., Dunia G., Bitar M.A. The Use of Topical Intranasal Antibiotics in Pediatric Chronic Rhinosinusitis. Ann Otolaryngol Rhinol. 2016;3(12):1150. Available at: https://www.researchgate.net/publication/314465071_The_Use_of_Topical_Intranasal_Antibiotics_in_Pediatric_Chronic_Rhinosinusitis.
21. Karpova E.P., Tulupov D.A. About the possibilities of nebulizer therapy in the treatment of acute rhinosinusitis in children. Rossiyskaya otorinolaringologiya = Russian Otorhinolaryngology. 2013;(4):160–163. (In Russ.) Available at: http://entru.org/files/preview/2013/04/j_rus_LOR_4_2013.pdf.
22. Kunel’skaja N.L., Turovskij A.B., Izotova G.N., Talalajko Ju.V., Kiseljova O.A. Possibilities of inhaled use of combination drugs in the treatment of acute sinusitis. Meditsinskiy sovet = Medical Council 2014;(1):28–31. (In Russ.) doi: 10.21518/2079-701X-2014-3-28-31.
23. Angotoeva I.B., Pshennikov D.S. The inhalation therapy of moderate forms of acute bacterial rhinosinusitis. Meditsinskiy sovet = Medical Council. 2018;(6):84–88. (In Russ.) doi: 10.21518/2079-701X-2018-6-84-88.
24. Yanov Yu.K., Daikhes N.A., Abdulkerimov Kh.T., Artyushkin S.A., Aslanov B.I., Vakhrushev S.G. et. al. Resolution of the council of experts of the NMAO on the problem of antibiotic therapy in otorhinolaryngology of november 4, 2018. Rossiyskaya otorinolaringologiya = Russian Otorhinolaryngology. 2019;18(1):135–138. (In Russ.)
Review
For citations:
Karpova EP, Tulupov DA, Zyabkin IV. Topical antibiotics for acute rhinosinusitis in children. Meditsinskiy sovet = Medical Council. 2020;(6):50-56. (In Russ.) https://doi.org/10.21518/2079-701X-2020-6-50-56